Your session is about to expire
← Back to Search
Prosthetic Device
NU-FlexSIS Prosthetic Socket for Leg Amputation
N/A
Recruiting
Led By Stefania Fatone, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up all participants: baseline period weeks 0, 4, 8, 12; intervention group: intervention period weeks 0, 4, 8, 12, 16, 20, 24; reference group: monitoring period weeks 4, 12, 20, 24.
Awards & highlights
Study Summary
This trial tests if a new prosthetic socket design improves comfort, wear time, mobility, participation, quality of life, and satisfaction for people with transfemoral amputations.
Who is the study for?
This trial is for adults over 18 with a below-knee amputation who have been using a prosthesis for at least a year. They should be able to perform limited community walking, use their upper limbs, and manage technology like computers or smartphones. Veterans are specifically included at VA sites. Participants must not plan to change their prosthetic knee or foot soon and cannot have certain health conditions like active cancer.Check my eligibility
What is being tested?
The study is testing the NU-FlexSIS, which is a new type of socket for leg prostheses designed to improve comfort and mobility compared to the standard socket used after thigh-level leg amputations. The goal is to see if this new design enhances quality of life, increases how long the prosthesis can be worn daily, and improves overall satisfaction.See study design
What are the potential side effects?
While specific side effects aren't listed for trying out a new prosthetic socket design like NU-FlexSIS, participants might experience discomfort or skin issues where the prosthesis attaches due to differences in fit or pressure distribution.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ all participants: baseline period weeks 0, 4, 8, 12; intervention group: intervention period weeks 0, 4, 8, 12, 16, 20, 24; reference group: monitoring period weeks 4, 12, 20, 24.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~all participants: baseline period weeks 0, 4, 8, 12; intervention group: intervention period weeks 0, 4, 8, 12, 16, 20, 24; reference group: monitoring period weeks 4, 12, 20, 24.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Socket Comfort Score (SCS)
Secondary outcome measures
Activities-specific Balance Confidence (ABC) Scale
Charlson Comorbidity Index (CCI)
Falls
+9 moreOther outcome measures
Amputee Mobility Predictor with Prosthesis (AMP-Pro)
International Society for Prosthetics and Orthotics (ISPO) Minimum Data Set for lower-limb prosthesis users involved Research Studies
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Participants will be assessed for 12 weeks in their usual ischial containment socket before receiving a subischial socket to be worn and assessed for 24 weeks.
Group II: Reference GroupActive Control1 Intervention
Participants will be assessed for 40 weeks in their usual ischial containment socket. No intervention will be provided.
Find a Location
Who is running the clinical trial?
Congressionally Directed Medical Research ProgramsFED
47 Previous Clinical Trials
6,463 Total Patients Enrolled
University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,651 Total Patients Enrolled
Stefania Fatone, PhDPrincipal InvestigatorUniversity of Washington
2 Previous Clinical Trials
110 Total Patients Enrolled
Media Library
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are the doors open to participants in this clinical trial?
"Clinicaltrials.gov notes that this particular medical trial, which was initially posted on the 1st of February 2023 and last modified on the 20th December 2022, is not currently seeking patients. Nevertheless, there are two alternative clinical trials recruiting at present."
Answered by AI
Share this study with friends
Copy Link
Messenger